Connective tissue growth factor and the parallels between brain injury and brain tumors

Journal of the National Cancer Institute

Volumn 103, Issue 15, 2011, Pages 1141-1143

  Halliday, John J ^a   Holland, Eric C ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CONNECTIVE TISSUE GROWTH FACTOR; FIBRONECTIN; HEPARIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIX METALLOPROTEINASE; PROTEIN TYROSINE KINASE A; UVOMORULIN; VASCULOTROPIN; ZINC FINGER PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN INFARCTION; BRAIN INJURY; BRAIN TUMOR; CANCER GRADING; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; EDITORIAL; GLIOBLASTOMA; GLIOSIS; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPINAL CORD INJURY; TRAUMATIC BRAIN INJURY; TUMOR MICROENVIRONMENT;

ANIMALS; ANTIGENS, CD29; ASTROCYTES; BINDING, COMPETITIVE; BRAIN INJURIES; BRAIN NEOPLASMS; CADHERINS; CELL MOVEMENT; CONNECTIVE TISSUE GROWTH FACTOR; ENZYME ACTIVATION; GLIOBLASTOMA; HOMEODOMAIN PROTEINS; HUMANS; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS; NF-KAPPA B; RECEPTOR, TRKA; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 79961226608     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djr261     Document Type: Editorial

References (18)

1. Edwards LA, Woolard K, Son MJ, et al. Effect of brain- and tumorderived connective tissue growth factor on glioma invasion. J Natl Cancer Inst. 2011;103(15):1162-1178.
2. Phanish MK, Winn SK, Dockrell MEC. Connective tissue growth factor-(CTGF, CCN2)-A marker, mediator and therapeutic target for renal fibrosis. Nephron Exp Nephrol. 2010;114(3):e83-e92.
3. Brigstock DR. The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocr Rev. 1999;20(2):189-206. (Pubitemid 29339590)
4. Xie D, Yin D, Wang H-J, et al. Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas. Clin Cancer Res. 2004;10(6):2072-2081. (Pubitemid 38375569)
5. Spliet WG, Aronica E, Ramkema M, Aten J, Troost D. Increased expression of connective tissue growth factor in amyotrophic lateral sclerosis human spinal cord. Acta Neuropathol. 2003;106(5):449-457. (Pubitemid 37265849)
6. Conrad S, Schluesener HJ, Adibzahdeh M, Schwab JM. Spinal cord injury induction of lesional expression of profibrotic and angiogenic connective tissue growth factor confined to reactive astrocytes, invading fibroblasts and endothelial cells. J Neurosurg Spine. 2005;2(3):319-326.
7. Schwab JM, Beschorner R, Nguyen TD, Meyermann R, Schluesener HJ. Differential cellular accumulation of connective tissue growth factor defines a subset of reactive astrocytes, invading fibroblasts, and endothelial cells following central nervous system injury in rats and humans. J Neurotrauma. 2001;18(4):377-388. (Pubitemid 32336544)
8. Demuth T, Rennert J, Hoelzinger D, et al. Glioma cells on the run-the migratory transcriptome of 10 human glioma cell lines. BMC Genomics. 2008;9(1):54.
9. Sofroniew MV. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 2009;32(12):638-647.
10. Robel S, Berninger B, Götz M. The stem cell potential of glia: lessons from reactive gliosis. Nat Rev Neurosci. 2011;12(2):88-104.
11. The Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455(7216):1061-1068.
12. Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, Batchelor TT. Angiogenesis in brain tumours. Nat Rev Neurosci. 2007;8(8):610-622. (Pubitemid 47093931)
13. Clement V, Sanchez P, de Tribolet N, Radovanovic I, Ruiz I, Altaba A. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol. 2007;17(2):165-172. (Pubitemid 46107823)
14. Amankulor NM, Hambardzumyan D, Pyonteck SM, Becher OJ, Joyce JA, Holland EC. Sonic hedgehog pathway activation is induced by acute brain injury and regulated by injury-related inflammation. J Neurosci. 2009;29(33):10299-10308.
15. Lukes A, Mun-Bryce S, Lukes M, Rosenberg GA. Extracellular matrix degradation by metalloproteinases and central nervous system diseases. Mol Neurobiol. 1999;19(3):267-284. (Pubitemid 29418895)
16. Chua HL, Bhat-Nakshatri P, Clare SE, Morimiya A, Badve S, Nakshatri H. NF-[kappa]B represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. Oncogene. 2006;26(5):711-724. (Pubitemid 46204250)
17. Bui T, Sequeira J, Wen TC, et al. ZEB1 links p63 and p73 in a novel neuronal survival pathway rapidly induced in response to cortical ischemia. PLoS One. 2009;4(2):e4373.
18. Ohashi S, Natsuizaka M, Wong GS, et al. Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB Transcription Factors. Cancer Res. 2010;70(10):4174-4184.